Zhihong Tang
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and efficacy of salvage surgery for unresectable hepatocellular carcinoma after conversion with triple therapy: a systematic review and meta-analysis of data from Chinese patients.
Journal: World journal of surgical oncology
Published: July 24, 2025
Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy.
Journal: Frontiers in immunology
Published: March 29, 2025
Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.
Journal: Frontiers in cellular and infection microbiology
Published: March 22, 2025
The Role of Timing of Progression and Early Salvage Surgery in Unresectable Hepatocellular Carcinoma Treated with TACE Plus TKIs and PD‑1 Inhibitors.
Journal: Journal of hepatocellular carcinoma
Published: June 07, 2024
Value of hepatic artery digital subtraction angiography in the detection of small hepatocellular carcinoma lesions.
Journal: Environmental toxicology
Published: February 24, 2024
TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study.
Journal: BMC cancer
Published: December 10, 2023
Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation.
Journal: International journal of nanomedicine
Published: June 22, 2023
Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 06, 2023
Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors.
Journal: Frontiers in oncology
Published: November 29, 2022
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation.
Journal: Frontiers in oncology
Published: December 14, 2021
Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
Journal: Translational cancer research
Published: October 02, 2019
Development and characterization of drug-loaded biodegradable PLA microcarriers prepared by the electrospraying technique.
Journal: International journal of molecular medicine
Published: September 03, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026